Clinical Trial Update: Biphasic Insulin Aspart Versus NPH Plus Regular Human Insulin in Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing biphasic insulin aspart with a NPH plus regular insulin combination in type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic insulin aspart
• NPH + regular insulin

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Diabetes Type 2 | Phase 4 | Status: COMPLETED